Answers are grounded in this paper and cite their sources.
Despite major recent progress in the treatment of indolent non-Hodgkin lymphomas (NHL), the optimal management of Waldenström macroglobulinemia (WM) remains a major clinical challenge. WM is genera...
No takes yet. Share an insight, caveat, or question.
Buske et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: